EUVIMEDEUVIMED entdecken
LeserbriefFallberichtVergleichsstudie

Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene

Yan Li, Qin Zhang, Haigang Shao

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05816-7 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of Hematology, 2024. Verfasst von Yan Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. Hauptthemen laut MEDLINE: Oncogene Proteins, Fusion, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Protein Kinase Inhibitors. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene Proteins, FusionPrecursor B-Cell Lymphoblastic Leukemia-LymphomaProtein Kinase InhibitorsFemaleHumansMaleAntineoplastic Combined Chemotherapy ProtocolsImmunotherapyIntracellular Signaling Peptides and ProteinsAdolescentMiddle Aged

Substanzen

Intracellular Signaling Peptides and ProteinsOncogene Proteins, FusionProtein Kinase InhibitorsRCSD1 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Department of Hematology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • Department of Hematology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China. xya3shg@163.com.

Zitieren

APA

Li, Y., Zhang, Q., & Shao, H. (2024). Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene. Annals of Hematology. https://doi.org/10.1007/s00277-024-05816-7

Vancouver

Li Y, Zhang Q, Shao H. Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene. Annals of Hematology. 2024. doi:10.1007/s00277-024-05816-7

BibTeX
@article{Li2024,
  author = {Li, Yan and Zhang, Qin and Shao, Haigang},
  title = {Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05816-7}
}
Kostenlos starten →